Cytotoxic Payloads for Antibody–Drug Conjugates

Discover the cutting-edge world of cancer treatment with Cytotoxic Payloads for Antibody–Drug Conjugates by Andreas Pahl. Published by the Royal Society of Chemistry in 2019, this comprehensive hardback spans 502 pages and delves into the innovative field of antibody-drug conjugates (ADCs). These therapeutic agents offer numerous advantages in anticancer drug discovery, including the ability to identify likely responders, efficient delivery of cytotoxic agents, and minimized toxicity for patients.

In this insightful book, Pahl explores the various payloads utilized in current ADCs as well as novel compounds that hold promise for future clinical applications. Whether you are a researcher, clinician, or student, this title is an essential addition to your library, providing valuable knowledge on the evolution and potential of ADCs in oncology.